•PRK linked to more postop dry eye, visual disturbances than LASIK•Legato startup debuts with AI-powered hearing glasses•Ocular Therapeutix reports positive pre-NDA FDA meeting for AXPAXLI•Essilor Stellest cut myopia progression 71% in US kids, US trial confirms•Opus Genetics releases positive phase 1/2 data in BEST1 retinal disease•PRK linked to more postop dry eye, visual disturbances than LASIK•Legato startup debuts with AI-powered hearing glasses•Ocular Therapeutix reports positive pre-NDA FDA meeting for AXPAXLI•Essilor Stellest cut myopia progression 71% in US kids, US trial confirms•Opus Genetics releases positive phase 1/2 data in BEST1 retinal disease
HEADLINES
FEATURED
Following significant investment, Sling advances oral small molecule therapy to late-stage clinical trial testing.
Earn FREE CE 24/7 with Courses by Eyes On Eyecare
Explore premium-quality, bite-sized courses featuring leading experts like Cecelia Koetting, OD, FAAO, and Cory Lappin, OD, MS, FAAO, and continuing education covering topics from ocular rosacea treatments to retinal disease.
